government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is
interest expenses in 2017 was Baht 14.3 million, or 4.26% decreased from Baht 15.0 million of 2016. This was due to lower short term loan requirement level in the second half of 2017 resulting from the lower
, taxes and depreciation (“EBITDA”) EBITDA (not included other income) decreased by 6% yoy but EBITDA margin remained at the same level of previous year which was 26%. This was attributable to the efficient
baht during 13-20 March 2020, and the reduction and cancelation of BOT bond issuance, while the Monetary Policy Committee has reduced the policy rate to the record-low level of 0.75 percent per year
% ( Total consolidated sales and services income excluding construction revenue under concession agreement of 2,100.73 million Baht, decreased by 121.19 million Baht or 5.45%) and Net profit attributable to
53.93% in 1Q’18. The consolidated profit before non-controlling interest of 9M’18 decreased by 5% yoy despite higher income and gross margin ratio. This was due to the impact from 2017 high base incurring
of the Thai baht and the intense competition which caused the exports to shrink from the previous year. Domestic consumption was also affected by high living expenses and household debt, as well as the
/ finance costs) decreased to 40x from 65x stemming from the increase of loans and decrease of shareholders’equity as mentioned above. As a result, debt to equity ratio increased but remained at low level of
expenses in Q2/2017 was Baht 4.0 million, or 3.47% decreased from Baht 4.1 million of Q2/2016. This was due to nearly the same short term loan requirement level and interest rate. As a result of the
uncertain environment including it has always changed. The consumer has had the existed burden of household liability in high level bring to decelerate the purchase by choosing the needful product and